F2 and Hepatic fibrosis: Factor V Leiden or prothrombin G20210A mutations were associated with an increased risk of clinically relevant liver fibrosis (defined as a liver stiffness > 8 kPa estimated by transient elastography) in the general population [42], corroborating the important role played by pro-thrombotic condition on liver fibrosis progression.